Treatment with non-selective beta-blockers affects the systemic inflammatory response to bacterial DNA in patients with cirrhosis.
Paula GimenezIrma Garcia-MartinezRubén FrancésJose M Gonzalez-NavajasMontserrat MauriRocío AlfayateSusana AlmenaraCayetano MirallesJose M PalazonFernando CarnicerSonia PascualJosé SuchJosé F HorgaPedro ZapaterPublished in: Liver international : official journal of the International Association for the Study of the Liver (2018)
In patients with cirrhosis, chronic treatment with beta-blockers is associated with a higher unstimulated production of serum cytokines and an increased phagocytic activity in the presence of bacterial DNA.